Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.04B |
| 2 |
Chevron
CVX
|
+$820M |
| 3 |
Shopify
SHOP
|
+$599M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$539M |
| 5 |
Meta Platforms (Facebook)
META
|
+$479M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Tesla
TSLA
|
+$661M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 4 |
Verizon
VZ
|
+$533M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.47% |
| 2 | Technology | 16.84% |
| 3 | Consumer Staples | 11.12% |
| 4 | Consumer Discretionary | 10.18% |
| 5 | Financials | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.3B
| $1.26M | ﹤0.01% |
+4,100
| New | +$1.34M |
|
2552
OptimizeRx
OPRX
$165M
| $1.26M | ﹤0.01% |
46,024
-43,976
| -49% | -$1.3M |
|
2553
Cathay General Bancorp
CATY
$4.31B
| $1.26M | ﹤0.01% |
+32,171
| New | +$1.31M |
|
2554
Enterprise Financial Services Corp
EFSC
$2.41B
| $1.26M | ﹤0.01% |
+30,300
| New | +$1.35M |
|
2555
Maui Land & Pineapple Co
MLP
$310M
| $1.25M | ﹤0.01% |
132,349
-2,800
| -2% | -$30.4K |
|
|
MNRL
2556
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $1.25M | ﹤0.01% |
50,800
+22,400
| +79% | +$618K |
|
|
CLPR
2557
Clipper Realty
CLPR
$53M
| $1.25M | ﹤0.01% |
161,857
-42,000
| -21% | -$361K |
|
2558
Donnelley Financial Solutions
DFIN
$1.17B
| $1.25M | ﹤0.01% |
42,600
-18,100
| -30% | -$537K |
|
2559
iShares Russell Mid-Cap ETF
IWR
$58.3B
| $1.25M | ﹤0.01% |
+19,300
| New | +$1.37M |
|
2560
Shattuck Labs
STTK
$735M
| $1.24M | ﹤0.01% |
306,500
+13,500
| +5% | +$48.9K |
|
2561
Vince Holding Corp
VNCE
$78.9M
| $1.24M | ﹤0.01% |
158,448
-2,600
| -2% | -$21.1K |
|
2562
Educational Development Corp
EDUC
$11.8M
| $1.24M | ﹤0.01% |
295,126
+600
| +0.2% | +$3.35K |
|
|
EXK
2563
Endeavour Silver
EXK
$3.05B
| $1.24M | ﹤0.01% |
394,167
+278,367
| +240% | +$1.1M |
|
2564
Kopin
KOPN
$898M
| $1.24M | ﹤0.01% |
1,103,439
+891,475
| +421% | +$1.34M |
|
2565
Riskified
RSKD
$863M
| $1.24M | ﹤0.01% |
278,300
-189,500
| -41% | -$981K |
|
2566
GeneDx Holdings
WGS
$2.36B
| $1.24M | ﹤0.01% |
29,716
+17,683
| +147% | +$1.2M |
|
|
NAGE
2567
Niagen Bioscience
NAGE
$241M
| $1.24M | ﹤0.01% |
739,900
+319,399
| +76% | +$625K |
|
2568
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$814M
| $1.24M | ﹤0.01% |
35,500
-62,312
| -64% | -$2.41M |
|
2569
Vanguard Ultra-Short Bond ETF
VUSB
$9.34B
| $1.24M | ﹤0.01% |
+25,100
| New | +$1.24M |
|
2570
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$306M
| $1.23M | ﹤0.01% |
+47,200
| New | +$1.2M |
|
|
CYBE
2571
DELISTED
Cyberoptics Corp
CYBE
| $1.23M | ﹤0.01% |
35,300
+17,600
| +99% | +$721K |
|
2572
Century Casinos
CNTY
$34.3M
| $1.23M | ﹤0.01% |
170,949
-40,738
| -19% | -$380K |
|
|
ABCM
2573
DELISTED
Abcam PLC
ABCM
| $1.23M | ﹤0.01% |
85,149
+34,900
| +69% | +$540K |
|
2574
Cadre Holdings
CDRE
$1.44B
| $1.23M | ﹤0.01% |
+62,500
| New | +$1.47M |
|
2575
MeiraGTx Holdings
MGTX
$1.17B
| $1.23M | ﹤0.01% |
+162,300
| New | +$1.57M |
|
Similar funds
Jim Simons's Q2 2022 Portfolio in Review
As of Q2 2022, Jim Simons held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $13.7B of net new capital in Q2 2022, opening 694 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.
- Jim Simons's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
- Jim Simons added most to Chevron in Q2 2022, an estimated $820M increase.
- Jim Simons's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
- Jim Simons fully exited Amazon in Q2 2022, selling an estimated $675M.
- Jim Simons's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
- Jim Simons opened 694 new positions and closed 562 in Q2 2022.
- Jim Simons's portfolio value fell 0.87% quarter-over-quarter to $84.5B.
Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.